Several preclinical studies reported that the combination of low-dose fractionated radiation therapy and PD-1/PD-L1 axis inhibitors activates cytotoxic T cells infiltrating and immediately surrounding the tumour [37]. The gene discussed is CD274; the disease is neoplasm.